Business Standard

Sunday, December 22, 2024 | 12:31 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Sensex, Nifty march higher on Covid-19 vaccine progress news; ONGC rises 6%

After touching a record intra-day high of 44,271.15, Sensex ended 194.90 points or 0.44 per cent higher at 44,077.15

People walk past the Bombay Stock Exchange (BSE) building in Mumbai. Photo: Reuters
Premium

People walk past the Bombay Stock Exchange (BSE) building in Mumbai. Photo: Reuters

Press Trust of India
Equity benchmarks made a winning start to the week on Monday as positive results from another Covid-19 vaccine candidate bolstered investor confidence globally.

After touching a record intra-day high of 44,271.15, Sensex ended 194.90 points or 0.44 per cent higher at 44,077.15. Similarly, the broader Nifty rose 67.40 points or 0.52 per cent to close at 12,926.45.

ONGC was the top performer on the Sensex chart, surging 6.84 per cent, followed by IndusInd Bank, Infosys, Tech Mahindra, Bajaj Finserv, Reliance Industries, HCL, and TCS.

Index heavyweight Reliance Industries climbed 2.72 per cent, acco­u­nting for most of the Sensex’s gains.

On the other hand, the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in